Neurodegenerative disorders, such as #Alzheimers or #Parkinsons disease, can affect patients’ cognitive or motor functions. Current standards of care focus on managing these symptoms, but it can take years for them to appear. Episode 9 of our podcast, The Persistence Lab, explores how understanding the lived experiences of patients with brain disorders can unlock insights to help inform #neuroscience research focused on slowing disease progression. Listen to the full conversation with our experts: https://bit.ly/4viC25A 🎙️
Tentang kami
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
Link eksternal untuk AbbVie
- Industri
- Manufaktur Farmasi
- Ukuran perusahaan
- 10.001+ karyawan
- Kantor Pusat
- North Chicago, Illinois
- Jenis
- Perusahaan Publik
- Spesialisasi
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, Eye Care
Lokasi
Karyawan di AbbVie
Update
-
Happy #Pride Month! To celebrate, AbbVie employees David, Mariko and Hayley share their experience as members of the Pride Employee Resource Group and the importance of creating space where everyone feels they belong. #BelongAtAbbVie [Video description: AbbVie employee David O., Mariko N. and Hayley D. share how being part of the Pride Employee Resource group has helped them bring their authentic selves to work and impacted them personally and professionally.]
-
This year at the European Hematology Association (EHA) Annual Meeting, we presented new data in diffuse large-B-cell lymphoma (#DLBCL) and follicular lymphoma (#FL), in partnership with Genmab. Our mission is focused on advancing cancer research aimed at improving outcomes for patients. For more information on our work in #BloodCancer and oncology focus areas, visit: https://bit.ly/43BDhAI #EHA2026
-
We’re presenting data at the European Hematology Association (EHA) Congress across chronic lymphocytic leukemia (#CLL), including combination treatment efficacy and safety profiles. Learn more: https://bit.ly/49XHOAX [Video description: On-screen text reads, “Oncology News.”]
-
AbbVie is at the European Hematology Association (EHA) Congress this week, showcasing our clinical advancements from research programs across multiple blood cancers and connecting with the global community to address persisting unmet needs in blood cancer. Learn more: https://bit.ly/4dTLtlM [On-screen text reads, “New Data Being Presented at EHA. June 11-14.”]
-
-
On World Environment Day, we recognize the importance of this year's Climate Action theme – and the role collective action plays in advancing it. Through our annual AbbVie Ecochallenge, which encourages employees to sustain and adapt eco-friendly habits, employees across 47 countries completed more than 160,000 actions — a reminder that sustainability is something we can practice every day. 🌍 #NowForClimate
-
AbbVieClinicalTrials.com has been redesigned to simplify how people connect with our clinical trials. Visit the website to search ongoing trials, explore clinical insights and scientific resources, and more: https://lnkd.in/e2AtPfc3
-
Over the past 12 months, we've committed more than $2.2B to U.S. #manufacturing — and it's just the beginning. Take a look inside our "Factory of the Future," where #robotics, #AI and data analytics are working alongside skilled teams to deliver medicines faster and with uncompromising quality. The result: 1,300+ new high-value jobs and a smarter, more resilient supply of the medicines patients depend on. See how innovation is transforming the way we make medicines: https://lnkd.in/eVmsMBE6
-
Come along with us for a day in the life at the American Society of Clinical Oncology (ASCO) Annual Meeting in our hometown of Chicago. 📍 We’re sharing a behind-the-scenes look at the collaboration and connection taking place within the oncology community. Learn more about our research: https://bit.ly/3RIYciy #ASCO26
Halaman afiliasi
Halaman serupa
Pendanaan
AbbVie
Total 2 putaran
Lihat informasi selengkapnya di crunchbase
Putaran Terakhir
Hutang pasca IPO
Link Crunchbase Eksternal untuk putaran terakhir pendanaan
US$15.000.000.000,00